Insider selling
Traded Jul 3, 2025 · filed 4 days laterNot reported under a pre-arranged trading plan
A Moonlake Immunotherapeutics director sold $1.15M of Moonlake Immunotherapeutics shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
MLTX · NASDAQ · Pharmaceutical Preparations
Moonlake Immunotherapeutics (MLTX) · oqro.io/stocks/MLTX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$11.07+0.04 (+0.36%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Insider selling
Traded Jul 3, 2025 · filed 4 days laterNot reported under a pre-arranged trading plan
A Moonlake Immunotherapeutics director sold $1.15M of Moonlake Immunotherapeutics shares. The filing does not indicate a pre-arranged trading plan.
Traded Oct 4, 2024 · largest single transaction ~$51.5MNot reported under a pre-arranged trading plan
Oct 4, 2024~$51.5M · 1.03M sh @ $50.00
DetailsInsider selling
Traded Oct 4, 2024 · filed 4 days laterNot reported under a pre-arranged trading plan
A Moonlake Immunotherapeutics director sold $9.19M of Moonlake Immunotherapeutics shares. The filing does not indicate a pre-arranged trading plan.
Oct 4, 2024~$41.8M · 837K sh @ $50.00
DetailsOfficial recordOct 4, 2024~$6.63M · 133K sh @ $50.00
DetailsOfficial record0 open-market purchases and 0 open-market sales by insiders of MLTX between Jan 24, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 4, 2026. The data provider lists the next release for Feb 22, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 4, 2026 | None | None | None |
| Aug 10, 2026 | None | None | None |
| May 11, 2026 | None | None | None |
| Feb 23, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies